Skip to main content

I believe I killed my only friend...

If you follow me at all, you are aware of my current blog dilemma. I foolishly thought I could advance my readership and become a big girl blogger by changing over to a more well-known site. After over a week of daily tears, remorse, self-doubt, and abandonment, I have come to the conclusion that change is not always a good thing. 

At this time I no longer now the difference between "disable" and "enable" or "https" and that other "htt-whatever"; I think I may have inadvertently purchased mysterious stuff that will appear on my charge card bill; I have no idea why I am no longer receiving "views" on this site (What the h-e-double hockey sticks did I push?). I am forced to wonder how that MA and four undergrad degrees is helping me now. In fact, I am about to just chuck it all sand revert back to the days of recording in cursive all of my thoughts in my long-hand diary. At least I know I can still do that.

So, if there is anyone out there who can this for me, I am eternally grateful. Never have I felt so worthless that I cannot maneuver the simple(?) steps of setting up a Word Press site. And it not the fault of Word Press, or Blogger, or even President Trump. I just CANNOT do this.

Bottom line...I miss my friend, my blog. First thing in the morning, after a few yoga poses,  I bring my coffee with me to work on and now I have this fancy domain name (of which I was not too long ago rather proud). But what do I do with this new acquisition How do I use it to grow my readership, make new friends, and help fellow MS Warriors?

Help me!

Enough about me...

Just wanted to share this with anyone who might still receive notifications form this blog. Tomorrow evening there is a webinar about driving and MS. I plan to be there. Check out this site for more information:

It's not that learning more about our disease is fun, but at least MS makes more sense than all this technical jargon. 

Did I really just say that?


So, join the webinar and try to make sense of MS.



Popular posts from this blog

Alien feet?

Okay, so after my initial reunion with social media, I naively imagined today to be more productive. But, no...

For someone who doesn't spend much time perusing sites like Pinterest, my interest has suddenly piqued to the point that addiction be a possibility.

Hoping to find someone of like mind, I instead downloaded a slipper pattern I might knit for Christmas presents (oops, there goes the surprise). It looks fairly simple. Let me know if you give it a try.

And, then, I found this really neat yoga flow outlined for me.
Since yoga seems to be the go-to exercise for us Warriors, I decided to share. That way we do not have to invent our own personalized routine. You're welcome.

Then, I discovered an entire page of memes that put MS in perspective to the causal reader-reluctant  on-looker. And because  this figure is essentially in the child pose... well, you get the picture.

Of course, any information on foot drop always attracts my at…

You are invited to Letters to the MonSter

Well, the sun is shining at last and it appears that spring is sincerely here and hinting at summer weather.    That means I need a summer project; hopefully one that I can complete. With two young adult books   in various levels of completion, you will surely tells me how ridiculous I am to start yet another writing project. but, inspiration has no rules, right?
           The entire month of March MS Awareness Month led to so many
awesomeavenues of expressions, fueling my need to share and learn with 
fellow MS Warriors. So, let's hare. Let's learn. In Letters to the MonSter, 
my goal is to allow fellow Warriors to vent, scream, rant, and exorcise the  MonSter out of our lives. Let's unite in this project to erase multiple sclerosis from our lives. As Leslie Hillburn stated in the preface to my last tome to this disease, "...the ONLY place you will get any support and understanding in dealing with me (MS) is with Other People wi…

MS and children

FDA Approves First Treatment for Pediatric MS On May 11, 2018, Novartis announced that Gilenya® (fingolimod) was approved by the United States Food and Drug Administration (FDA) for the treatment of children and adolescents, ages 10 through 17, with relapsing multiple sclerosis (MS). This is the first disease-modifying therapy (DMT) to be approved for this form of the disease in this age group. Known as “pediatric MS,” nearly all of those diagnosed have the relapsing form of the disease. Children also experience approximately two-to-three times as many relapses as an individual with adult-onset MS. A clinical trial comparing Gilenya to Avonex® (interferon beta-1a) in children and adolescents found that those treated with Gilenya saw an 82-percent reduction in their annualized relapse rate over a period of up to two years. Please see MSAA's online news article, "FDA Approves Gilenya® for Pediatric MS,"for more information. If links are disabled in this email, please copy a…